Explore / Clinical trial
Clinical trial

Psilocybin in Cancer Pain Study

Yvan Beaussant, MD, MSciRecruitingPhase 2Started Sep 23, 202415 enrolledUnited StatesNCT06001749

Abstract

The overall objective of this study is to assess the feasibility, safety and preliminary efficacy of psilocybin-assisted therapy to alleviate opioid-refractory pain in patients with advanced-cancer. The name of the study intervention used in this research study is: Psilocybin (a tryptamine derivative)

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

PsilocybinAddictionPainPalliative care

Keywords

Opioid-Related DisordersPain ManagementPain Management and CareAdvanced CancerAdvanced CancersOpioid-Related DisordersPain ManagementPain Management and CareAdvanced CancerAdvanced Cancers

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.